PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurod…
Category: News
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted seven newly-hired non-executive employees stock options to purchas…
Generic SpA Screening Tool Needed Across Comorbid Diseases
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients with uveitis or IBD, compared with psoriasis. Medscape Medical News
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)
DALLAS–(BUSINESS WIRE)—- $CE–Celanese Announces Commercial Launch of Glaukos’ iDose® TR (Travoprost Intracameral Implant) using Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA)
AI Chatbots vs Ophthalmology Specialists
A large language model demonstrated proficiency in ophthalmology, matching or outperforming specialists in the management of glaucoma and retina cases. Medscape Medical News
CA Suit Targets Anti-Bias Training in Health Care
The litigation is part of a national crusade by right-leaning advocacy and legal groups against diversity, equity, and inclusion, or DEI, initiatives in health care. KFF Health News
CA Suit Targets Anti-Bias Training in Healthcare
The litigation is part of a national crusade by right-leaning advocacy and legal groups against diversity, equity, and inclusion, or DEI, initiatives in health care. KFF Health News
Will 2024 Be Easier on the Eyes?
Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and office visits for retinal disease are on the horizon. Medscape Medical News
Warby Parker Announces Fourth Quarter and Full Year 2023 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2023….
National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2023 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ended December 30, 2023, and is providing its outlook for fiscal…
FDA OKs 10th Humira Biosimilar, Interchangeability Included
It is the tenth adalimumab biosimilar approved by the regulatory agency. Medscape Medical News
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair
BERWYN, Pa.–(BUSINESS WIRE)–Amring, a subsidiary of Nordic Pharma, will have preeminent ophthalmologist Eric D. Donnenfeld, MD Chair its U.S. Medical Advisory Board.
Novos recursos fabricados na Suíça para a seleção de lentes para cirurgia de catarata
NEUCHATEL, Suíça–(BUSINESS WIRE)–A empresa Swiss Advanced Vision (SAV-IOL SA) anunciou o lançamento de novos recursos para a sua calculadora tórica, que aprimora a experiência geral de cálculo. Pela primeira vez, os oftalmologistas serão capazes de u…
白内障手术镜片选择的新瑞士制造特性
瑞士, 纳沙泰尔–(BUSINESS WIRE)–(美国商业资讯)– Swiss Advanced Vision (SAV-IOL SA)宣布推出其扭曲计算器的新功能,以改善整体计算体验。眼科医生首次能够利用基于患者光学参数的网络配置器来帮助确定最佳的切口位置,以最小化手术后残留的散光。而且,适用于所有类型的镜片。 SAV-IOL扭曲计算器有助于选择扭曲人工晶体,帮助矫正散光,这是一种普遍的眼睛状况,会导致视力模糊、不适和潜在的头痛。 除了独特的切口位置优化工具能指示残余散光何时在切口角度下达…
白內障手術鏡片選擇的瑞士製造新特性
瑞士, 紐夏泰爾–(BUSINESS WIRE)–(美國商業資訊)– Swiss Advanced Vision(SAV-IOL SA)宣布推出其Toric計算器的新功能,以提升整體計算體驗。這是眼科醫生首次能夠使用網絡配置器,根據患者的光學參數幫助確定最佳的切口位置,以最大限度地減少手術後的殘餘散光。而且,適用於所有類型的鏡片。 SAV-IOL Toric Calculator能夠協助選擇扭曲人工晶體,以糾正散光,這是一種普遍的眼睛問題,會導致視力模糊、不適和潛在的頭痛。 除了獨特的切口位置…
Nuevas funciones Swiss Made para la selección de lentes para la cirugía de cataratas
NEUCHATEL, Suiza–(BUSINESS WIRE)–La empresa Swiss Advanced Vision (SAV-IOL SA) anunció el lanzamiento de nuevas funciones para su Calculadora de Tóricos que mejoran la experiencia general de cálculo. Por primera vez, los oftalmólogos podrán utilizar …
Samenvatting: In Zwitserland krijgt de selectie van lenzen nieuwe functies voor staaroperaties
NEUCHATEL, Zwitserland–(BUSINESS WIRE)–Het bedrijf Swiss Advanced Vision (SAV-IOL SA) heeft aangekondigd dat het nieuwe functies voor zijn Toric Calculator heeft ontwikkeld om de algehele berekeningservaring te verbeteren. Voor het eerst kunnen oogar…
Neue in der Schweiz entwickelte Funktionen zur Auswahl der Linsen für die Kataraktchirurgie
NEUCHATEL, Schweiz–(BUSINESS WIRE)–Das Unternehmen Swiss Advanced Vision (SAV-IOL SA) hat die Einführung neuer Funktionen für seinen Toric Calculator bekannt gegeben, durch die die Benutzerfreundlichkeit bei der Berechnung insgesamt verbessert wurde….
For Retina Specialists, 2024 Is a Time to Try New Tools
This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond. Medscape Medical News
Aptar Digital Health Announces Acquisition of Healint to Reinforce Digital Health Portfolio and Drive Future Growth
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Digital Health Announces Acquisition of Healint to Reinforce Digital Health Portfolio and Drive Future Growth